The Sacubitril/Valsartan, a First-in-Class, Angiotensin Receptor Neprilysin Inhibitor (ARNI): Potential Uses in Hypertension, Heart Failure, and Beyond

被引：0
|
作者：
Kazuomi Kario
机构：
[1] Jichi Medical University School of Medicine (JMU),Division of Cardiovascular Medicine, Department of Medicine
[2] JMU Center of Excellence,undefined
[3] Community Medicine Cardiovascular Research and Development (JCARD),undefined
来源：
Current Cardiology Reports | 2018年 / 20卷
关键词：
Sacubitril/valsartan; Angiotensin receptor neprilysin inhibitor (ARNI); Resistant hypertension; Cardiovascular continuum; Nocturnal hypertension; Systolic hypertension; Central blood pressure; Heart failure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Initial clinical experience with the first drug (sacubitril/valsartan) in a new class - angiotensin receptor neprilysin inhibitors in patients with heart failure with reduced left ventricular ejection fraction in Poland
    Kaluzna-Oleksy, Marta
    Kolasa, Jolanta
    Migaj, Jacek
    Pawlak, Agnieszka
    Lelonek, Malgorzata
    Nessler, Jadwiga
    Straburzynska-Migaj, Ewa
    KARDIOLOGIA POLSKA, 2018, 76 (02) : 381 - 387
  • [32] Six months clinical and echocardiographic outcome of angiotensin receptor-neprilysin inhibitor (sacubitril/valsartan) therapy in heart failure patients with reduced ejection fraction
    Alnims, M. Mohammed
    Magdy, Abdelhamid
    Meguid, M. Abdel
    Ahmed, Shehata
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 101 - 102
  • [33] Effect of the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide
    Ayalasomayajula, Surya
    Schuehly, Uwe
    Pal, Parasar
    Chen, Fabian
    Zhou, Wei
    Sunkara, Gangadhar
    Langenickel, Thomas H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (05) : 926 - 936
  • [34] Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor
    Ayalasomayajula, Surya P.
    Langenickel, Thomas H.
    Jordaan, Pierre
    Zhou, Wei
    Chandra, Priyamvada
    Albrecht, Diego
    Pal, Parasar
    Rajman, Iris
    Sunkara, Gangadhar
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (09) : 1065 - 1073
  • [35] Impact of ARNI (Angiotensin Receptor Neprilysin Inhibitor) on functional status of patients with heart failure and reduced ejection fraction (HFrEF)
    Soofi, M. A. Muhammad Adil
    Alsamadi, F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 442 - 443
  • [36] Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor
    Ayalasomayajula, Surya
    Langenickel, Thomas
    Pal, Parasar
    Boggarapu, Sreedevi
    Sunkara, Gangadhar
    CLINICAL PHARMACOKINETICS, 2017, 56 (12) : 1461 - 1478
  • [37] Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor
    Surya P. Ayalasomayajula
    Thomas H. Langenickel
    Pierre Jordaan
    Wei Zhou
    Priyamvada Chandra
    Diego Albrecht
    Parasar Pal
    Iris Rajman
    Gangadhar Sunkara
    European Journal of Clinical Pharmacology, 2016, 72 : 1065 - 1073
  • [38] Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor–Neprilysin Inhibitor
    Surya Ayalasomayajula
    Thomas Langenickel
    Parasar Pal
    Sreedevi Boggarapu
    Gangadhar Sunkara
    Clinical Pharmacokinetics, 2018, 57 : 105 - 123
  • [39] Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor
    Surya Ayalasomayajula
    Thomas Langenickel
    Parasar Pal
    Sreedevi Boggarapu
    Gangadhar Sunkara
    Clinical Pharmacokinetics, 2017, 56 : 1461 - 1478
  • [40] Effects of the angiotensin receptor-neprilysin inhibitor/sacubitril-valsartan administration on quality of life and outcome in heart failure with reduced ejection fraction: a meta analysis
    Dewi, Kadek Intan Murti
    Pintaningrum, Yusra
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0F)
12345